Scribble in hematopoietic stem cell activity
Scribble in hematopoietic stem cell activity
批准号:
9934991
负责人:
Mark Jordan Althoff
金额:
$3.75万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-01 至 2020-03-31
关键词:
AssesBlood CellsBone MarrowCell CycleCell Cycle InhibitionCell Cycle ProgressionCell Differentiation processCell PolarityCell ProliferationCell physiologyCellsChronic DiseaseComplexConfocal MicroscopyCuesCytoplasmDataDevelopmentDiseaseEuchromatinExhibitsFailureFlow CytometryGeneticGenetic DiseasesGenetic TranscriptionGoalsHematological DiseaseHematologyHematopoiesisHematopoieticHematopoietic SystemHematopoietic stem cellsImageIndividualInterferon Type IInterferonsInterventionLabelLarvaLeucine-Rich RepeatMalignant NeoplasmsMeasuresMediatingMesenchymal Stem CellsMolecularMolecular TargetMusNuclearNuclear TranslocationOrgan SizePathway interactionsPharmacologyPhosphorylationPhosphotransferasesPopulationProteinsRegulationResearch PersonnelResistanceResponse ElementsReverse Transcriptase Polymerase Chain ReactionRoleSTAT1 geneSTAT2 geneSignal PathwaySignal TransductionStem cell transplantStem cellsStressStructureTestingTherapeuticTranslatingTransplantationVirus DiseasesWorkcancer geneticscell behaviorcell typechemotherapycytokinecytopeniaexhaustionhematopoietic stem cell fatehematopoietic stem cell quiescencehematopoietic stem cell self-renewalimprovedin vivoinsightleukemiamembermutantnovelpolarized cellprogenitorprogramspublic health relevancereconstitutionresponseself-renewaltranscriptome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The potential of hematopoietic stem cells (HSC) to reconstitute the hematopoietic system has allowed for the development of transplantation approaches to treat cancer and hematologic diseases. Cell cycle status of HSC defines their ability to engraft in conditioned recipients and has been hypothesized as a mechanism for chemotherapy-resistant HSC-derived leukemias. HSC are highly quiescent cells with the ability to rapidly enter the cell cycle and differentiate through changes in their polarity and disposition
of intracellular molecular fate determinants in response to microenvironment (ME) cues. In bone marrow (BM) hematopoiesis, interferons type I (IFN-I), a ME cytokine produced in response to viral infection, have been shown to be a crucial positive regulator to induce proliferation of otherwise quiescent hematopoietic stem cells (qHSC). Our preliminary data indicate that Scribble deficient HSC are insensitive to IFN-I and retain cellular quiescence in vivo. Our preliminary data also show that the Hippo effector Yap1, which also regulates stem cell proliferation in response to ME signals, is polarized and co-localizes in the cytoplasm with Scribble in wild type HSC. Deficiency of Scribble in HSC results in Yap1 translocation to nuclear euchromatin suggesting a novel Scribble-mediated mechanism used to protect qHSC from potential damage associated with cellular activation. Our data suggests that Scribble distinctly regulates HSC cell cycle progression in a context-dependent manner. We believe that ME IFN-I induced HSC proliferative signaling program depends on Scribble and that Scribble deficiency abrogates HSC polarization leading to reduced quiescence and subsequent HSC exhaustion through activation of downstream Hippo effectors. To gain insight into these ME dependent signaling pathways that control HSC activity, we plan to analyze both IFN-I response signaling pathways and Hippo signaling in Scribble proficient and deficient HSC. We will utilize flow cytometry and confocal microscopy to define a role for Scribble in mediating such signals. Functionally, we will test the reconstitution abilities of wild type and Scribble structure-functio mutants in Scribble deficient HSC through serial transplantations. Dissecting the microenvironment dependent Scribble-mediated molecular mechanisms that govern HSC quiescence will help refine the significance and therapeutic potential of naturally occurring IFN molecules and identify novel targets for intervention in HSC disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the unique dependency for MCL1 in Ven/Aza resistant AML
-
批准号:10535785
-
项目类别:
-
资助金额:$6.92万
-
财政年份:2022
-
负责人:Mark Jordan Althoff
-
依托单位:
Understanding the unique dependency for MCL1 in Ven/Aza resistant AML
-
批准号:10671482
-
项目类别:
-
资助金额:$7.34万
-
财政年份:2022
-
负责人:Mark Jordan Althoff
-
依托单位:
Scribble in hematopoietic stem cell activity
-
批准号:9122838
-
项目类别:
-
资助金额:$3.6万
-
财政年份:2016
-
负责人:Mark Jordan Althoff
-
依托单位:
Scribble in hematopoietic stem cell activity
-
批准号:9269077
-
项目类别:
-
资助金额:$3.65万
-
财政年份:2016
-
负责人:Mark Jordan Althoff
-
依托单位:
海外基金